Seeking Alpha

Seeking Alpha Portfolio App for iPad

Jason Napodano

Jason Napodano picture

Profile

Send Message

View as an RSS Feed

View Jason Napodano's Articles BY TICKER:

FDA Throws Pozen A Curveball
on Fri, Apr 27, 2012 • POZN • 10 Comments
Big Step Forward For InVivo
on Fri, Apr 13, 2012 • NVIV.OB • 11 Comments
Pivotal FDA Decision Upcoming For Alexza
on Wed, Apr 11, 2012 • ALXA • 16 Comments
Zalicus Bolsters Cash Position
on Wed, Mar 28, 2012 • ZLCS • 17 Comments
Modeling Shows Depomed Undervalued
on Fri, Mar 9, 2012 • SNTS, DEPO • 25 Comments
Anacor Looks Right For A Long-Term Play
on Mon, Feb 27, 2012 • GSK, ANAC • 3 Comments
Here's Why We Like InVivo Therapeutics
on Thu, Jan 19, 2012 • NVIV.OB • Comment!
Investors Waiting For Aastrom To Raise Cash
on Thu, Jan 12, 2012 • ASTM • 4 Comments
Twelve Biotech Picks For 2012
on Thu, Dec 22, 2011 • ASTM, ACAD, ALXA • 9 Comments
Pozen Deal Unlocks Value
on Mon, Nov 28, 2011 • AZN, POZN • Comment!
InVivo Soon To Enter Clinical Testing
on Tue, Nov 15, 2011 • NVIV.OB • Comment!
Aastrom Bio: Final RESTORE Data Looks Solid
on Tue, Nov 15, 2011 • ASTM • 4 Comments
Neurocrine Looks Well-Positioned For The Future
on Tue, Nov 1, 2011 • ABT, NBIX • 1 Comment
Titan Pharmaceuticals: Pre-NDA Meeting Brings Positive News
on Thu, Oct 27, 2011 • TTNP.OB • 3 Comments
What To Do With Depomed Now
on Fri, Oct 14, 2011 • SNTS, MRK, JNJ • 4 Comments
Alexza's Agitation Drug Back Under Review - Trade the Upcoming Catalysts
on Tue, Aug 9, 2011 • ALXA • 3 Comments
Trius: Increased Cash Position, Lower Costs, and High Cash Flow
on Thu, Jul 28, 2011 • TSRX • 4 Comments
Zalicus: Undervalued, With Strong Pipeline Potential
on Thu, Jul 7, 2011 • ZLCS • 19 Comments
Medtronic and Nile See Promise in Heart Failure Treatment Trials
on Tue, Jun 28, 2011 • MDT, NLTX.PK, JNJ • Comment!
Bullish on Aastrom
on Fri, Jun 3, 2011 • SNY, CEPH, ASTM • 13 Comments
Optimistic on Titan - Initiating Coverage With Outperform
on Wed, Jun 1, 2011 • TTNP.OB • 4 Comments
Optimistic on Acadia: Solid Cash Position, Increased Confidence in Phase 3 Trial
on Tue, Apr 26, 2011 • ACAD • 11 Comments
Competition Between Aastrom Bio and Pluristem Heating Up
on Mon, Apr 18, 2011 • PSTI, ASTM • 16 Comments
Cytori: A Must Own Biotech
on Wed, Apr 13, 2011 • CYTX • 8 Comments
Potential Competition Between Depomed and XenoPort: What Shareholders Should Consider
on Tue, Mar 29, 2011 • XNPT, DEPO, GSK • 35 Comments
Bullish on Trius Therapeutics
on Thu, Mar 24, 2011 • TSRX, PFE, CBST • 6 Comments
Oxygen Biotherapeutics Gets Sales Boost From U.S. and Europe
on Wed, Mar 23, 2011 • OXBT • 2 Comments
All Eyes on Alexza as Company Prepares to Re-File Drug Application
on Wed, Mar 16, 2011 • ALXA • 46 Comments
Inhibitex Ready for a Breakout Year
on Fri, Mar 11, 2011 • INHX, PFE, MRK • 8 Comments
What's Pozen Really Worth?
on Tue, Mar 8, 2011 • POZN, GSK, AZN • 26 Comments
Sell-Off Creates Opportunity in Aastrom Bio
on Tue, Mar 1, 2011 • ASTM • 33 Comments
Nile Teams With Medtronic for Post-Acute Heart Failure
on Mon, Feb 28, 2011 • NLTX.PK, MDT • Comment!